ZA201702639B - Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis - Google Patents
Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosisInfo
- Publication number
- ZA201702639B ZA201702639B ZA2017/02639A ZA201702639A ZA201702639B ZA 201702639 B ZA201702639 B ZA 201702639B ZA 2017/02639 A ZA2017/02639 A ZA 2017/02639A ZA 201702639 A ZA201702639 A ZA 201702639A ZA 201702639 B ZA201702639 B ZA 201702639B
- Authority
- ZA
- South Africa
- Prior art keywords
- osteoporosis
- prevention
- treatment
- pharmaceutical compositions
- aromatic compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/32—Phenylacetic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462062597P | 2014-10-10 | 2014-10-10 | |
| PCT/CA2015/000540 WO2016054728A1 (en) | 2014-10-10 | 2015-10-08 | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201702639B true ZA201702639B (en) | 2018-06-27 |
Family
ID=55652429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2017/02639A ZA201702639B (en) | 2014-10-10 | 2017-04-12 | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20180228750A1 (enExample) |
| EP (1) | EP3203999B1 (enExample) |
| JP (1) | JP6700639B2 (enExample) |
| KR (1) | KR20170066476A (enExample) |
| CN (1) | CN106999456B (enExample) |
| AR (1) | AR102246A1 (enExample) |
| AU (1) | AU2015330645B2 (enExample) |
| BR (1) | BR112017007426A2 (enExample) |
| CA (1) | CA2963354A1 (enExample) |
| DK (1) | DK3203999T3 (enExample) |
| ES (1) | ES2785317T3 (enExample) |
| IL (1) | IL251404B (enExample) |
| MX (1) | MX376873B (enExample) |
| MY (1) | MY194308A (enExample) |
| PH (1) | PH12017500638A1 (enExample) |
| PL (1) | PL3203999T3 (enExample) |
| PT (1) | PT3203999T (enExample) |
| RU (1) | RU2709205C2 (enExample) |
| SG (1) | SG11201702868VA (enExample) |
| TW (1) | TWI699200B (enExample) |
| UY (1) | UY36356A (enExample) |
| WO (1) | WO2016054728A1 (enExample) |
| ZA (1) | ZA201702639B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016054725A1 (en) * | 2014-10-10 | 2016-04-14 | Prometic Biosciences Inc. | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
| AU2015345943B2 (en) * | 2014-11-12 | 2020-03-19 | Liminal Biosciences Limited | Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration |
| CN107683135A (zh) | 2015-03-09 | 2018-02-09 | 因特克林医疗有限公司 | 用于治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法 |
| KR20190065252A (ko) * | 2016-08-18 | 2019-06-11 | 인테크린 테라퓨틱스, 아이엔씨. | 골 질환 치료용 PPARγ 작용제 |
| AU2018249822A1 (en) | 2017-04-03 | 2019-10-31 | Coherus Biosciences Inc. | PPArgamma agonist for treatment of progressive supranuclear palsy |
| AU2021356346A1 (en) * | 2020-10-06 | 2023-06-15 | Pharmaceutique Ingenew Inc. | Substituted aromatic compounds and pharmaceutical compositions thereof |
| MX2024005982A (es) * | 2021-11-17 | 2024-05-30 | Natreon Inc | Withania somnifera y asparagus racemosus en el tratamiento de enfermedades posmenopausicas. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200720256A (en) * | 2005-05-13 | 2007-06-01 | Synta Pharmaceuticals Corp | IL-12 modulatory compounds |
| EP2427416B1 (en) * | 2009-05-04 | 2016-03-09 | Prometic Pharma Smt Limited | Substituted aromatic compounds and pharmaceutical uses thereof |
| BRPI1015118A2 (pt) * | 2009-05-04 | 2016-04-12 | Prometic Biosciences Inc | sais de ácido pentilfenilacético e usos farmacêuticos dos mesmos |
| PH12013500763B1 (en) * | 2010-10-27 | 2018-07-04 | Prometic Pharma Smt Ltd | Phenylketone carboxylate compounds and pharmaceutical uses thereof |
| CN105997967B (zh) * | 2010-10-27 | 2019-08-23 | 普罗米蒂克医药Smt有限公司 | 用于治疗癌症的化合物和组合物 |
| TWI742541B (zh) * | 2013-03-15 | 2021-10-11 | 英商邊緣生物科技有限公司 | 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物 |
| TWI689490B (zh) * | 2013-03-15 | 2020-04-01 | 英商邊緣生物科技有限公司 | 用於治療纖維化之經取代之芳族化合物及相關方法 |
| WO2016054725A1 (en) * | 2014-10-10 | 2016-04-14 | Prometic Biosciences Inc. | Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
-
2015
- 2015-10-08 PL PL15849675T patent/PL3203999T3/pl unknown
- 2015-10-08 EP EP15849675.2A patent/EP3203999B1/en active Active
- 2015-10-08 JP JP2017518905A patent/JP6700639B2/ja not_active Expired - Fee Related
- 2015-10-08 WO PCT/CA2015/000540 patent/WO2016054728A1/en not_active Ceased
- 2015-10-08 TW TW104133254A patent/TWI699200B/zh not_active IP Right Cessation
- 2015-10-08 MX MX2017004733A patent/MX376873B/es active IP Right Grant
- 2015-10-08 KR KR1020177011332A patent/KR20170066476A/ko not_active Ceased
- 2015-10-08 RU RU2017116178A patent/RU2709205C2/ru active
- 2015-10-08 PT PT158496752T patent/PT3203999T/pt unknown
- 2015-10-08 AU AU2015330645A patent/AU2015330645B2/en not_active Ceased
- 2015-10-08 SG SG11201702868VA patent/SG11201702868VA/en unknown
- 2015-10-08 DK DK15849675.2T patent/DK3203999T3/da active
- 2015-10-08 CA CA2963354A patent/CA2963354A1/en not_active Abandoned
- 2015-10-08 BR BR112017007426-5A patent/BR112017007426A2/pt not_active Application Discontinuation
- 2015-10-08 CN CN201580058623.7A patent/CN106999456B/zh not_active Expired - Fee Related
- 2015-10-08 US US15/516,643 patent/US20180228750A1/en not_active Abandoned
- 2015-10-08 MY MYPI2017000520A patent/MY194308A/en unknown
- 2015-10-08 ES ES15849675T patent/ES2785317T3/es active Active
- 2015-10-13 UY UY0001036356A patent/UY36356A/es not_active Application Discontinuation
- 2015-10-13 AR ARP150103294A patent/AR102246A1/es unknown
-
2017
- 2017-03-27 IL IL251404A patent/IL251404B/en active IP Right Grant
- 2017-04-06 PH PH12017500638A patent/PH12017500638A1/en unknown
- 2017-04-12 ZA ZA2017/02639A patent/ZA201702639B/en unknown
-
2020
- 2020-04-09 US US16/844,813 patent/US11185521B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268316B (en) | Pharmaceutical preparations for combined treatment | |
| ZA201906613B (en) | Pharmaceutical compositions for combination therapy | |
| ZA201706007B (en) | Pharmaceutical compositions for combination therapy | |
| IL250890A0 (en) | Compounds for the inhibition of indoleamine-2-3-dioxygenase and pharmaceutical preparations containing them | |
| SG11201801024XA (en) | Therapeutic or preventive compositions for il-8-related diseases | |
| IL261444A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis | |
| ZA201905510B (en) | Pharmaceutical compositions for combination therapy | |
| EP3182989A4 (en) | Methods and compositions for the prevention and treatment of disease | |
| IL251404A0 (en) | Altered aromatic compounds and medicinal preparations for the prevention and treatment of osteoporosis | |
| EP3231436A4 (en) | Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient | |
| PL3130353T3 (pl) | Kompozycja farmaceutyczna na bazie nanostruktury grafenu do zapobiegania lub leczenia chorób neurodegeneracyjnych | |
| GB201401086D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
| PL3081228T3 (pl) | Iryzyna do leczenia i zapobiegania osteoporozie | |
| SG11201702812PA (en) | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes | |
| ZA201703579B (en) | Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration | |
| EP3253379A4 (en) | Pharmaceutical composition for the treatment of obesity | |
| IL251409A0 (en) | Compounds of phenylketone carboxylate and their pharmaceutical preparations for the prevention and treatment of osteoporosis | |
| PL3164110T3 (pl) | Kompozycje farmaceutyczne do leczenia łuszczycy | |
| HK1236421A1 (en) | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| IL236381A0 (en) | Pharmaceutical preparations for the treatment of cancer | |
| AU2014904579A0 (en) | Compositions and methods for treatment or prophylaxis of a liver condition |